Hermetica Superfood Encyclopedia
The Short Answer
Procyanidin B2 is a dimeric flavan-3-ol proanthocyanidin composed of two epicatechin units linked by a B-type bond, found in high concentrations in apple skin, grape seeds, and cocoa. It exerts antioxidant and anti-glycation effects primarily by scavenging reactive oxygen species and inhibiting the Maillard reaction pathway that produces advanced glycation end-products.
CategoryCompound
GroupCompound
Evidence LevelModerate
Primary KeywordProcyanidin B2 benefits
Procyanidin B2 — botanical close-up
Health Benefits
**Antioxidant Protection**
Procyanidin B2 scavenges reactive oxygen species (ROS) and chelates pro-oxidant metal ions through its polyhydroxyl catechol rings, reducing oxidative stress markers in preclinical models at nanomolar-to-micromolar concentrations.
**Anti-Glycation Activity**
PC B2 inhibits formation of advanced glycation end-products including pentosidine, carboxymethyllysine (CML), and methylglyoxal (MGO) adducts, suggesting potential utility in managing glycation-associated complications in metabolic diseases.
**Neuroprotection**
Oral administration of PC B2 at 40 mg/kg in rat cerebral ischemia models significantly reduced infarct volume and brain edema, with dose-dependent neuroprotective effects observed across 10, 20, and 40 mg/kg dosing groups.
**Cardiovascular Support**
PC B2 has demonstrated anti-hypertensive properties in preclinical studies, consistent with broader proanthocyanidin mechanisms including endothelial nitric oxide (NO) pathway modulation and vascular smooth muscle relaxation, though specific human trial data remain limited.
**Anti-Inflammatory Effects**
Through inhibition of pro-inflammatory transcription factors and reduction of lipid peroxidation end-products, PC B2 attenuates inflammatory cascades relevant to atherosclerosis and ischemic tissue injury in animal models.
**Gut Microbiome Interaction**
PC B2 undergoes extensive microbial biotransformation in the gastrointestinal tract, generating 53 identified metabolites including lower molecular weight fragments (e.g., m/z 291) via C4–C8 bond cleavage, which may independently exert systemic bioactivity after intestinal absorption.
**Metabolic Health Support**
By suppressing AGE accumulation and reducing oxidative burden, PC B2 may help protect against diabetes-associated vascular and tissue damage, though direct human metabolic outcome data are not yet established.
Origin & History
Natural habitat
Procyanidin B2 is a naturally occurring dimeric flavan-3-ol found in concentrated amounts in grape seeds (Vitis vinifera), apples (Malus domestica), cocoa beans (Theobroma cacao), and red wine. It forms biosynthetically via oxidative coupling of two epicatechin units joined by a C4→C8 interflavan bond during plant secondary metabolism, with concentrations varying substantially by cultivar, growing conditions, and fruit maturity. Grape seeds represent one of the richest commercial sources, yielding high-purity extracts (>98%) used in nutritional and pharmaceutical research.
“Procyanidin B2 as an isolated chemical entity has no distinct history of traditional use; however, the plant sources richest in PC B2 — particularly grape seeds, red wine, and apples — carry centuries of ethnobotanical and folk medicine application. In ancient Greek and Roman traditions, grape preparations were used to treat inflammatory conditions, circulatory disorders, and wound healing, with Dioscorides referencing astringent grape seed preparations in De Materia Medica (circa 50–70 CE). The broader category of oligomeric proanthocyanidins gained modern scientific prominence in the 1950s–1970s through the work of French chemist Jacques Masquelier, who isolated and characterized grape seed proanthocyanidins (marketed as 'pycnogenol' before the term was restricted to maritime pine bark extract) and demonstrated vascular capillary-protective effects. Contemporary interest in PC B2 specifically emerged from late 20th-century advances in HPLC fractionation of polyphenols, enabling isolation and structural characterization of individual procyanidin dimers from complex plant matrices.”Traditional Medicine
Scientific Research
The evidence base for procyanidin B2 consists predominantly of in vitro biochemical assays and preclinical animal studies, with no published randomized controlled human clinical trials identified in the current literature. Key preclinical pharmacokinetic work in rats (n=5 for mass balance, n=9 for blood profiling) using oral doses of 10.5–21 mg/kg demonstrated a blood Cmax at approximately 6 hours post-dose, apparent bioavailability of 8–11% by blood AUC, and urinary recovery of 63% of radioactive label within 96 hours, indicating that metabolite absorption is substantial even when intact compound absorption is limited. Neuroprotection studies in rat cerebral ischemia models showed dose-dependent reduction in infarct volume and brain edema at 10–40 mg/kg oral doses, with 40 mg/kg producing the greatest effect, though no control comparisons to standard-of-care agents were reported. Metabolite profiling in mice identified 53 biotransformation products (45 characterized, 24 novel), establishing PC B2 as a metabolically complex compound, but the translation of these preclinical findings to human therapeutic contexts requires dedicated Phase I/II clinical investigation.
Preparation & Dosage
Traditional preparation
**Research-Grade Powder**
7 mg/mL), ethanol (≥42
High-purity isolate (>98% PC B2) available in milligram-to-gram quantities; soluble in DMSO (≥40..4 mg/mL), and water (≥23.95 mg/mL); used exclusively in preclinical and in vitro studies.
**Grape Seed Extract (standardized)**
Commercial supplements typically standardized to 95% oligomeric proanthocyanidins (OPCs), of which PC B2 is one constituent; standardized PC B2 content per capsule is rarely declared on labels.
**Apple Polyphenol Extract**
100–300 mg per serving without PC B2-specific quantification
Derived from unripe apple skin and flesh; contains PC B2 among mixed proanthocyanidins; commonly sold at .
**Preclinical Effective Doses**
10–40 mg/kg oral in rats for neuroprotection; 10
5–21 mg/kg for pharmacokinetic characterization — no validated human equivalent dose established.
**Timing**
Rat studies show peak blood levels at approximately 6 hours post-oral administration; human absorption timing is extrapolated but unconfirmed — with-food administration may slow but improve total exposure based on general polyphenol pharmacology.
**Standardization Note**
No regulatory body has established a standardized human supplemental dose for isolated procyanidin B2; clinical use remains investigational.
Nutritional Profile
Procyanidin B2 is a pure polyphenolic compound (C30H26O12, MW 578.52 g/mol) with no caloric, macronutrient, or conventional micronutrient contribution. As a dietary constituent, it is consumed in microgram-to-milligram quantities per serving: a 100 g serving of apples may provide several milligrams of total procyanidins, with PC B2 representing a cultivar-dependent fraction; grape seeds and red wine contribute higher concentrations on a dry-weight basis, though serving-level quantities vary considerably. Bioavailability of intact PC B2 is low (8–11% apparent bioavailability in rats), substantially limited by gut microbial degradation prior to absorption, though 82% of ingested label is recovered as metabolites in urine within 96 hours in rat mass balance studies, indicating near-complete biotransformation. Co-consumption with other dietary polyphenols may modulate gut microbial processing; the presence of bile acids, dietary fat, and competing phenolic substrates can alter microbial enzyme availability and thus the metabolite profile generated from PC B2.
How It Works
Mechanism of Action
Procyanidin B2 scavenges free radicals through its catechol ring hydroxyl groups, donating hydrogen atoms to neutralize reactive oxygen species and reactive carbonyl species. It inhibits advanced glycation end-product (AGE) formation by trapping reactive dicarbonyls such as methylglyoxal (MGO) and glyoxal, reducing the accumulation of pentosidine and N-carboxymethyllysine (CML) cross-links in proteins. Additionally, it may modulate the Nrf2-Keap1 antioxidant signaling pathway, upregulating endogenous antioxidant enzymes including superoxide dismutase and glutathione peroxidase.
Clinical Evidence
Most available evidence for Procyanidin B2 comes from in vitro cell culture studies and animal models, with limited human clinical trial data specific to this isolated compound. In vitro studies demonstrate dose-dependent inhibition of AGE formation and measurable free radical scavenging capacity, though translation to human physiological concentrations remains uncertain. Some human trials examining procyanidin-rich extracts from apple or grape seed include Procyanidin B2 as a constituent but do not isolate its individual contribution, making it difficult to attribute specific outcomes to this compound alone. Overall, evidence quality for Procyanidin B2 as a standalone ingredient is considered preliminary, and robust randomized controlled trials with standardized dosing are lacking.
Safety & Interactions
Procyanidin B2 is generally considered safe when consumed through dietary sources such as apples, cocoa, and grapes, with no established tolerable upper intake level for isolated supplemental forms. High doses of proanthocyanidin-rich extracts have occasionally been associated with mild gastrointestinal discomfort including nausea and loose stools in sensitive individuals. Because procyanidins may inhibit iron absorption by forming insoluble complexes with non-heme iron, individuals with iron deficiency anemia should exercise caution with supplemental forms taken alongside iron-rich meals. Pregnant and breastfeeding women should avoid high-dose isolated Procyanidin B2 supplements due to insufficient safety data, and individuals on anticoagulant medications such as warfarin should consult a physician given theoretical additive effects observed with related polyphenols.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
PC B2Procyanidin B-2CAS 29106-49-8epicatechin-(4β→8)-epicatechindimeric proanthocyanidin B2
Frequently Asked Questions
What foods are highest in Procyanidin B2?
Apple skin is among the richest dietary sources of Procyanidin B2, with concentrations reported between 100–300 mg per 100 g of fresh skin depending on variety. Cocoa powder, dark chocolate, and grape seeds also contain notable amounts, while cinnamon and certain berries provide smaller quantities of this specific dimer.
How does Procyanidin B2 inhibit advanced glycation end-products?
Procyanidin B2 traps reactive carbonyl intermediates — particularly methylglyoxal (MGO) and glyoxal — that form during the Maillard reaction, chemically adducting to these dicarbonyls before they can react with lysine and arginine residues on proteins. This reduces downstream accumulation of AGEs including N-carboxymethyllysine (CML) and pentosidine cross-links, which are implicated in diabetic complications, skin aging, and vascular stiffness.
Is Procyanidin B2 effective for hair growth?
Procyanidin B2 extracted from apples has been investigated in small clinical trials for androgenetic alopecia, with one Japanese study (n=29) reporting a statistically significant increase in terminal hair count after 6 months of topical application compared to placebo. However, these studies used proprietary topical formulations rather than oral supplements, and evidence remains insufficient to recommend supplemental Procyanidin B2 for hair loss without further large-scale trials.
What is the difference between Procyanidin B2 and Procyanidin B1?
Both are dimeric proanthocyanidins composed of two flavan-3-ol units, but they differ in their linkage configuration: Procyanidin B2 consists of two epicatechin units joined by a C4β→C8 bond, while Procyanidin B1 is formed by an epicatechin and a catechin unit with the same bond type. This structural difference affects their polarity, bioavailability, and specific reactivity with carbonyl compounds and free radicals.
Can Procyanidin B2 supplements interact with medications?
Procyanidin B2 and related proanthocyanidins may theoretically potentiate anticoagulant drugs like warfarin or clopidogrel by inhibiting platelet aggregation and modulating arachidonic acid pathways, though direct clinical interaction data for isolated Procyanidin B2 are lacking. It may also reduce oral iron absorption by chelating non-heme iron in the gastrointestinal tract, and preliminary evidence suggests possible inhibition of CYP450 enzymes at high concentrations, warranting caution with drugs that have narrow therapeutic windows.
What is the bioavailability of Procyanidin B2 and how is it absorbed?
Procyanidin B2 has relatively low oral bioavailability due to its large molecular structure and susceptibility to degradation by gut microbiota, with some studies showing less than 5% systemic absorption of the intact compound. However, the catabolites produced by colonic bacteria—including phenolic metabolites like phenylvalerolactone—may contribute to its biological activity in the body. Consumption with food, particularly fats and proteins, may enhance absorption efficiency, though individual microbiome composition significantly influences bioavailability variability.
Who would benefit most from Procyanidin B2 supplementation?
Individuals with elevated oxidative stress, diabetes risk, or concerns about skin aging may benefit from Procyanidin B2, as research demonstrates its antioxidant and anti-glycation properties in these populations. People with poor dietary intake of proanthocyanidin-rich foods—such as apples, grapes, cocoa, and berries—are candidates for supplementation to achieve therapeutic concentrations. Those experiencing age-related cognitive or cardiovascular concerns may also find value, though clinical evidence in humans remains preliminary for these applications.
How does Procyanidin B2 compare to other proanthocyanidins in terms of antioxidant strength?
Procyanidin B2 is a dimeric proanthocyanidin with potent free radical scavenging capacity at nanomolar concentrations, though larger polymeric proanthocyanidins (trimers and higher oligomers) often demonstrate greater total antioxidant power due to increased numbers of reactive hydroxyl groups. However, B2's smaller size and specific catechol ring structure provide superior bioavailability compared to larger procyanidins, making it more likely to reach systemic circulation intact. The optimal antioxidant benefit often comes from a mixture of proanthocyanidins of varying chain lengths rather than isolated B2 alone.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w procyanidin-b2 curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
